Purpura, Varholak and Smith of Richards Barry Joyce & Partners represent BioMed Realty Trust Inc. and AVEO Pharmaceuticals, Inc. in 126,000 s/f lease

BioMed Realty Trust, Inc. and AVEO Pharmaceuticals, Inc. have signed a new 12-year lease for 126,000 s/f of laboratory and office space at 650 East Kendall St., in Kendall Sq. AVEO will move its headquarters and primary research facilities to the six-story, multi-tenant research facility that is owned through BioMed Realty's joint venture with Prudential Real Estate Investors on behalf of institutional investors. Richards Barry Joyce & Partners brokered the lease between the two companies. BioMed was represented by RBJ's Steven Purpura, partner, and AVEO was represented by RBJ's Jonathan Varholak, partner, and Eric Smith, senior vice president. According to Alan Gold, BioMed's chairman and chief executive officer, "We are pleased to welcome AVEO to 650 East Kendall and Kendall Sq., the ideal location for their mission-critical research and clinical development of cancer therapeutics. 650 East Kendall was built to the exacting requirements of world-class life science tenants in order to support transformational research, such as AVEO's new treatments for the medical oncology community and their patients." The 650 East Kendall property is comprised of a 280,000 s/f research facility that is supported by six levels of below-grade parking. The building received Gold status certification by the Leadership in Energy and Environmental Design (LEED) of the U.S. Green Building Council.